Hi Taurean7
Re the COVID 19 Test Kits
I would suggest you take a closer look at Note 5 (page 14) of the more recent Half Year Accounts 31 Dec 2020 (ASX Announcement 18 Feb 2021 CELLMID APPENDIX 4D – 1H FY2021 BUSINESS ACTIVITY) where:
Diagnostics – finished goods at net realisable value were " - " ( "dash" this generally means Nil as in the COVID 19 test kits purchased appear to have have been written off IMHO) 30 Jun 2020 $234,223
Further quote from Note 5.
"During the reporting period additional provisioning of inventories to net realisable value equalled $217,666 (December
2019: $nil). The net expense was included in the cost of sales for the period ended 31 December 2020."
Cheers
Finny
- Forums
- ASX - By Stock
- Midkine and COVID 19
Hi Taurean7Re the COVID 19 Test KitsI would suggest you take a...
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online